Related Experiment Video
Updated: Jul 28, 2026

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
Published on: February 4, 2015
LCAT deficiency and pregnancy: Case report.
Raul Leal-Gonzalez1, Álvaro Ramos-Reyes1, Mariana Moncada-Madrazo1
1Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo Leon, Mexico.
Lecithin-cholesterol acyltransferase (LCAT) deficiency in pregnancy presents risks like pancreatitis and fetal growth restriction. Early delivery resulted in a healthy infant, offering insights for managing this rare lipid disorder.
Area of Science:
- Lipid Metabolism
- Genetics
- Obstetrics
Background:
- Lecithin-cholesterol acyltransferase (LCAT) deficiency is a rare autosomal recessive disorder impacting lipid metabolism.
- Prevalence is less than 1:1,000,000, making it a significant diagnostic challenge.
Observation:
- A 29-year-old pregnant woman with LCAT deficiency experienced recurrent hypertriglyceridemia-induced pancreatitis and nephrotic-range proteinuria.
- Fetal ultrasounds indicated progressive fetal growth restriction (FGR) during the second and third trimesters.
Findings:
- The patient underwent an elective cesarean section at 33 weeks gestation.
- A healthy neonate was delivered, despite the maternal condition.
Implications:
- This case highlights the complex interplay between LCAT deficiency and pregnancy.
- Understanding the natural history of LCAT deficiency during gestation is crucial for optimizing patient and fetal outcomes.
- Findings can inform future management strategies for pregnant individuals with LCAT deficiency.
More Related Videos
10:44A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
Published on: June 2, 2019
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity